Sequela, Inc., is a biotechnology company that focuses on the research and development of diagnostics and therapeutics for human disease. Sequela is involved in the developmnt of an Enzyme-Linked Immunosorbent Assay or ELISA for hypertensive people that can be used to distinguish between salt sensitive and salt insensitive patients.
